RCS - Aptamer Group PLC - Investor Webinar

AptamerAnnouncement

04/12/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241204:nRSD6808Oa&default-theme=true

RNS Number : 6808O  Aptamer Group PLC  04 December 2024

 

 

REACH: non-regulatory announcement

 

 

 

4 December 2024

 

Aptamer Group plc

 

("Aptamer", the "Company" or the "Group")

 

Investor Webinar

 

Aptamer Group plc (AIM: APTA), the developer of novel Optimer(®) binders
to enable innovation in the life sciences industry, announces that Dr Arron
Tolley, Chief Executive Officer and Dr David Bunka, Chief Scientific Officer
will be hosting a webinar on Thursday, 12 December 2024 at 6.00 pm (GMT).

 

The webinar will provide investors with a valuable opportunity to interact
with the Company and gain insights into recent announcements.

 

There will be a Q&A session for investors after the presentation and
questions can be submitted pre-event as part of the registration process.

 

You can register for the event by using the following link:

https://www.turnerpope.com/register/
(https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.turnerpope.com%2Fregister%2F&data=05%7C02%7CAndy.Thacker%40TurnerPope.com%7Cb70ead4c470f43a159b608dd13a2681a%7Cff82bd738fe84a38a86994e58a240e55%7C0%7C0%7C638688310462430630%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=gInM1PlCMvpmR0Yxm2X20M834TUFDdcoRrfbPmN%2FJ74%3D&reserved=0)

 

We are delighted to announce that the webinar will be chaired by experienced
news and corporate events presenter Katie Pilbeam (www.katiepilbeam.com
(http://www.katiepilbeam.com) ) and hosted by the Company's broker, Turner
Pope Investments.

 

- Ends -

 

For further information, please contact:

 

 Aptamer Group plc                                               +44 (0) 1904 217 404 

 Arron Tolley, Chief Executive Officer
 SPARK Advisory Partners Limited - Nominated Adviser             +44 (0) 20 3368 3550 

 Andrew Emmott / Adam Dawes 
 Turner Pope Investments (TPI) Limited - Broker                  +44 (0) 20 3657 0050 

 James Pope / Andrew Thacker 
 Northstar Communications Limited - Investor Relations           +44 (0) 113 730 3896

 Sarah Hollins

 

About Aptamer Group plc

 

Aptamer Group develops custom affinity binders through its proprietary
Optimer(®) platform to enable new approaches in therapeutics, diagnostics,
and research applications. The Company strives to deliver transformational
solutions that meet the needs of life science researchers and developers.

 

Optimer binders are oligonucleotide affinity ligands that can function as an
antibody alternative. The global affinity ligand market is currently worth
over $170 billion.

 

Aptamer has successfully delivered projects for a range of global pharma
companies, diagnostic development companies, and research institutes, covering
multiple application areas with the objective of establishing royalty-bearing
licenses.

 

To register for news alerts by email go to
https://aptamergroup.com/investors/investor-news-email-alerts/
(https://aptamergroup.com/investors/investor-news-email-alerts/) .

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFSEFADELSEDE